Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...

Check the time stamp on this data. Updated AI-Generated Signals for Biontech Se (BNTX) available here: BNTX. Type a few ...

What To Know: Moderna, whose stock plunged 23% Monday ... it allows you to profit off of the share price decline. According to data from Benzinga Pro, BNTX has a 52-week high of $131.49 and ...

If an investor was to purchase shares of BNTX stock at the current price level of $114.21/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

BioNTech SE Sponsored ADR (BNTX) closed the last trading session at $112.76, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...